Oliver Domenig

1.3k total citations
56 papers, 870 citations indexed

About

Oliver Domenig is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Oliver Domenig has authored 56 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 29 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Molecular Biology. Recurrent topics in Oliver Domenig's work include Renin-Angiotensin System Studies (32 papers), Hormonal Regulation and Hypertension (28 papers) and Blood Pressure and Hypertension Studies (6 papers). Oliver Domenig is often cited by papers focused on Renin-Angiotensin System Studies (32 papers), Hormonal Regulation and Hypertension (28 papers) and Blood Pressure and Hypertension Studies (6 papers). Oliver Domenig collaborates with scholars based in Austria, United States and Germany. Oliver Domenig's co-authors include Marko Poglitsch, Srinivas Sriramula, Huijing Xia, Marlies Antlanger, Jiaxi Xu, Lisa Moreno‐Walton, Christopher C. Kaltenecker, Marcus D. Säemann, Eric Lazartigues and J Kovarík and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Oliver Domenig

53 papers receiving 863 citations

Peers

Oliver Domenig
Sara B. Police United States
Nicola E. Clarke United Kingdom
Rajesh Kabra United States
Oliver Domenig
Citations per year, relative to Oliver Domenig Oliver Domenig (= 1×) peers Yuji Tatara

Countries citing papers authored by Oliver Domenig

Since Specialization
Citations

This map shows the geographic impact of Oliver Domenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Domenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Domenig more than expected).

Fields of papers citing papers by Oliver Domenig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Domenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Domenig. The network helps show where Oliver Domenig may publish in the future.

Co-authorship network of co-authors of Oliver Domenig

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Domenig. A scholar is included among the top collaborators of Oliver Domenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Domenig. Oliver Domenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holbrook, Todd C., Jorge A. Hernández, Taralyn M. McCarrel, et al.. (2025). Renin-Angiotensin-Aldosterone System Profiling in Horses Before and After Exercise. Journal of Veterinary Internal Medicine. 39(2). e70036–e70036.
2.
Lindner, Christian, Éva Hunyadi‐Gulyás, Zsuzsanna Darula, et al.. (2025). Characterizing SV40-hTERT Immortalized Human Lung Microvascular Endothelial Cells as Model System for Mechanical Stretch-Induced Lung Injury. International Journal of Molecular Sciences. 26(2). 683–683.
3.
Krenn, Katharina, et al.. (2024). Intra- and postoperative relative angiotensin II deficiency in patients undergoing elective major abdominal surgery. Frontiers in Endocrinology. 15. 1375409–1375409. 1 indexed citations
4.
Šimko, Fedor, Peter Stanko, Kristina Repova, et al.. (2024). Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system. Biomedicine & Pharmacotherapy. 173. 116391–116391. 2 indexed citations
6.
Ames, Marisa K., et al.. (2023). The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease. Journal of Veterinary Internal Medicine. 37(3). 875–886. 11 indexed citations
7.
Hartl, Lukas, Oliver Domenig, Benedikt Simbrunner, et al.. (2023). The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation. Scientific Reports. 13(1). 953–953. 14 indexed citations
8.
Ward, Jessica, et al.. (2022). Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy. Journal of Veterinary Internal Medicine. 36(3). 897–909. 14 indexed citations
9.
Briand, François, Valentin Sencio, Cyril Robil, et al.. (2022). Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters. Viruses. 14(9). 2067–2067. 10 indexed citations
10.
Ward, Jessica, et al.. (2021). Suspected primary hyperreninism in a cat with malignant renal sarcoma and global renin-angiotensin-aldosterone system upregulation. Journal of Veterinary Internal Medicine. 36(1). 272–278. 1 indexed citations
11.
Kovarík, J, Christopher C. Kaltenecker, Oliver Domenig, et al.. (2021). Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study. Diabetes Therapy. 12(9). 2485–2498. 7 indexed citations
12.
Bovée, Dominique M., Liwei Ren, Estrellita Uijl, et al.. (2021). Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease. Hypertension. 77(5). 1600–1612. 22 indexed citations
13.
Pávó, Noémi, Suriya Prausmüller, Georg Spinka, et al.. (2021). Myocardial Angiotensin Metabolism in End-Stage Heart Failure. Journal of the American College of Cardiology. 77(14). 1731–1743. 13 indexed citations
14.
Taschler, Ulrike, Oliver Domenig, Marko Poglitsch, et al.. (2020). Dipeptidyl peptidase 3 modulates the renin–angiotensin system in mice. Journal of Biological Chemistry. 295(40). 13711–13723. 40 indexed citations
15.
Kaltenecker, Christopher C., Oliver Domenig, Chantal Kopecky, et al.. (2020). Critical Role of Neprilysin in Kidney Angiotensin Metabolism. Circulation Research. 127(5). 593–606. 25 indexed citations
16.
Adin, Darcy B., Clarke E. Atkins, Oliver Domenig, et al.. (2020). Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism. Journal of Veterinary Internal Medicine. 34(2). 600–606. 21 indexed citations
17.
Kovarík, J, Christopher C. Kaltenecker, Chantal Kopecky, et al.. (2019). Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation. Scientific Reports. 9(1). 9762–9762. 12 indexed citations
18.
Domenig, Oliver, Arndt Manzel, Nadja Grobe, et al.. (2016). Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney. Scientific Reports. 6(1). 33678–33678. 70 indexed citations
19.
Veghel, Richard van, René de Vries, Ingrid M. Garrelds, et al.. (2015). Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats. Kidney International. 88(1). 109–120. 39 indexed citations
20.
Manzel, Arndt, Oliver Domenig, Ágnes Zsófia Kovács, et al.. (2014). Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease. Journal of Neuroimmune Pharmacology. 9(4). 533–543. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026